Abstract
Background
Within the last years TAVI—especially transfemoral/transvascular TAVI—has proven to be a valuable therapeutic option for most patients suffering from AS. Here, we present the outcome of a complete dataset of all patients undergoing aortic valve replacement in Germany in 2018.
Methods
The data of all aortic valve procedures performed in Germany in 2018 derive from the mandatory nationwide quality control program. Patients were stratified with a new version of the German Aortic valve score (AKL Score) divided in different risk stratification depending on the treatment with either a catheter based (TV-TAVI) or surgical (iSAVR) approach. In-hospital outcomes have been compared between the two approaches.
Results
19,317 transvascular (TV)–TAVI procedures were carried out. In contrast to this steady growth, the number of iSAVR andtransapical (TA) -TAVI procedures declined. In-hospital mortality after TV-TAVI (2.5%) was lower when compared to iSAVR (3.1%) as well as TA-TAVI (5.7%) in-hospital mortality after TV-TAVI was significantly lowest (Fig. 2) with an in-hospital mortality rate of 2.5%. TV-TAVI was the only approach with an observed vs. expected mortality ratio < 1 according to the used risk prediction model.
Conclusion
TV-TAVI is more often performed and shows lower in-hospital mortality than iSAVR. TV-TAVI has replaced iSAVR as the gold-standard concerning in-hospital outcome in aortic stenosis management.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Leon M, Smith C, Mack M, Miller D, Moses J, Svensson L, Tuzcu M, Webb J, Fontana G, Makkar R, Brown D, Block P, Guyton R, Pichard A, Bavaria J, Herrmann H, Douglas P, Peterson J, Akin J, Anderson W, Wand D, Pcocock S for the PTI (2010) Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 363:1597–1607
Smith C, Leon M, Mack M, Miller D, Moses J, Svnesson L, Tuzcu E, Webb J, Fontana G, Makkar R, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani V, Corso P, Pichard A, Bavaria J, Herrmann H, Akin J, Anderson W, Wang D, PS for the PTI (2011) Transcatheter versus surgical aotic-valve replacement in high-risk patients. N Engl J Med 364:2187–2198
Leon MB, Smith CR, Mack MJ et al (2016) Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med 374:1609–1620. https://doi.org/10.1056/NEJMoa1514616
Mack M, Leon M, Thourani V et al (2019) Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. https://doi.org/10.1056/nejmoa1814052(Epub ahead of print)
Popma J, Deeb G, Yakubov S et al (2019) Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med. https://doi.org/10.1056/nejmoa1816885(Epub ahead of Print)
Gaede L, Blumenstein J, Liebetrau C et al (2018) Outcome after transvascular transcatheter aortic valve implantation in 2016. Eur Heart J 39:667. https://doi.org/10.1093/eurheartj/ehx688
Gaede L, Blumenstein J, Liebetrau C et al (2019) Transvascular transcatheter aortic valve implantation in 2017. Clin Res Cardiol. https://doi.org/10.1007/s00392-019-01509-8
Bekeredjian R, Szabo G, Balaban Ü et al (2018) Patients at low surgical risk as defined by the Society of Thoracic Surgeons Score undergoing isolated interventional or surgical aortic valve implantation: in-hospital data and 1-year results from the German Aortic Valve Registry (GARY). Eur Heart J. https://doi.org/10.1093/eurheartj/ehy699
Kim WK, Hamm CW (2018) Transcatheter aortic valve implantation in Germany. Clin Res Cardiol Suppl 2:81–87. https://doi.org/10.1007/s00392-018-1297-0
Kim W-K, Blumenstein J, Liebetrau C et al (2017) Comparison of outcomes using balloon-expandable versus self-expanding transcatheter prostheses according to the extent of aortic valve calcification. Clin Res Cardiol. https://doi.org/10.1007/s00392-017-1149-3
Gaede L, Blumenstein J, Kim W-K et al (2017) Trends in aortic valve replacement in Germany in 2015: transcatheter versus isolated surgical aortic valve repair. Clin Res Cardiol. https://doi.org/10.1007/s00392-016-1070-1
Gaede L, Kim WK, Liebetrau C et al (2018) Pacemaker implantation after TAVI: predictors of AV block persistence. Clin Res Cardiol 107:60–69. https://doi.org/10.1007/s00392-017-1158-2
Kim W-K, Liebetrau C, van Linden A et al (2016) Myocardial injury associated with transcatheter aortic valve implantation (TAVI). Clin Res Cardiol 105:379–387. https://doi.org/10.1007/s00392-015-0949-6
Gaede L, Kim W-K, Blumenstein J et al (2017) Temporal trends in transcatheter and surgical aortic valve replacement. Herz 42:316–324. https://doi.org/10.1007/s00059-016-4461-1
Baumgartner H, Falk V, Bax JJ et al (2017) 2017 ESC/EACTS Guidelines for the management of valvular heart disease The Task Force for the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European. Eur Heart J 38:2739–2791. https://doi.org/10.1093/eurheartj/ehx391
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
HM received speaker honoraria/proctor fees from Abbott, Biotronik, Boston Scientific, Edwards; OH and JB received proctor fees from Boston Scientific. LG receives speaker honoraria from Edwards and Abbott.
Rights and permissions
About this article
Cite this article
Möllmann, H., Husser, O., Blumenstein, J. et al. Lower mortality in an all-comers aortic stenosis population treated with TAVI in comparison to SAVR. Clin Res Cardiol 109, 611–615 (2020). https://doi.org/10.1007/s00392-019-01548-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-019-01548-1